Beneficiaries
Helmholz Zentrum München (coordinator), Germany
Bayer Aktiengesellschaft, Germany
Janssen Pharmaceutica NV , Belgium
Enamine Limited Liability Company, Ukraine
Freie Universität Berlin, Germany
Katholieke Universiteit Leuven, Belgium
Johannes Kepler Universität Linz, Austria
Scuola Universitaria Professionale della Svizzera Italiana, Switzerland
Universiteit Leiden, Netherlands
Université du Luxembourg, Luxembourg
Universitat Pompeu Fabra, Spain
Vancouver Prostate Center, University of British Columbia, Canada (own contribution)
Associated Partners
Technical University of Munich, Germany
University of Southern Switzerland
Novartis Institutes for Biomedical Research, Switzerland
University of North Carolina at Chapel Hill, USA
La Trobe University, Australia
Instituto di Ricerche Farmacologiche "Mario Negri", Italy